Manufacturers, Centers for Medicare & Medicaid Services (CMS), Negotiations

CMS 2026 IRA Price Negotiations Results Likely to Create Upstream and Downstream Effects

Mintz - Health Care Viewpoints on 8/20/2024

On August 15, 2024, CMS announced the results of the first round of the negotiated prices between CMS and participating drug manufacturers for the 10 selected drugs under the Inflation Reduction Act’s (IRA) Medicare Drug...more

Summary: The Government Accountability Office's Report on Medicare Part D Rebates

Ankura on 10/5/2023

On September 5, 2023, the United States Government Accountability Office (GAO) published its report titled Medicare Part D: CMS Should Monitor Effects of Rebates on Plan Formularies and Beneficiary Spending.The report...more

Mintz IRA Update — A Deeper Dive into Other Controversies of the IRA’s Medicare Drug Price Negotiation Program

Mintz - Health Care Viewpoints on 9/21/2023

The ability to directly negotiate drug prices has been a policy goal for Democrats for many years and was recently accomplished through the Inflation Reduction Act’s (“IRA”) Medicare Drug Price Negotiation Program (the...more

Mintz IRA Update — Other Key IRA Programs and Developments: The Medicare Prescription Drug Inflation Rebate Program and Maximum...

Mintz - Health Care Viewpoints on 9/21/2023

Although most of the recent focus around the implementation of the Inflation Reduction Act (“IRA”) by the press and industry stakeholders has been on the Medicare Drug Price Negotiation Program, the IRA has several other...more

Mintz IRA Update — Basics of the Medicare Drug Price Negotiation Program

Mintz - Health Care Viewpoints on 9/21/2023

The Inflation Reduction Act (“IRA”) was passed just over a year ago with a goal of lowering high drug costs for Medicare beneficiaries and reducing costs incurred by Medicare. A central piece to achieving the IRA’s goal of...more

In Proposed Regulations CMS Requests Information on Changes to Part D Negotiated Prices

Mintz - Health Care Viewpoints on 1/16/2018

Today, January 16, 2018 is the deadline for interested parties to submit comments to CMS regarding the proposed contract year 2019 Medicare Advantage and Part D regulations. The proposed rule focuses on many issues. In...more

Manufacturers › Centers for Medicare & Medicaid Services (CMS) › Negotiations

CMS 2026 IRA Price Negotiations Results Likely to Create Upstream and Downstream Effects

Summary: The Government Accountability Office's Report on Medicare Part D Rebates

Mintz IRA Update — A Deeper Dive into Other Controversies of the IRA’s Medicare Drug Price Negotiation Program

Mintz IRA Update — Other Key IRA Programs and Developments: The Medicare Prescription Drug Inflation Rebate Program and Maximum...

Mintz IRA Update — Basics of the Medicare Drug Price Negotiation Program

In Proposed Regulations CMS Requests Information on Changes to Part D Negotiated Prices

"My best business intelligence, in one easy email…"